This leads us to suggest that reduced dosage of either MBD5 or SATB2 causes neural stem cells to be more characteristic of differentiating cells than proliferating cells, and that this may be a unifying feature of neurodevelopmental disorders more generally. The gene discussed is SATB2; the disease is neurodevelopmental disorder.